Skip to main content
Log in

Antibiotic sensitivity of theBacteroides fragilis group in Europe

  • Article
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

Rates of resistance to 12 antibiotics were determined for 1,289 isolates of theBacteroides fragilis group submitted in 1988–1989 by 22 laboratories in 15 European countries. There was no resistance to metronidazole (breakpoint 8 mg/l) and only one isolate was resistant to chloramphenicol (breakpoint 8 mg/l). Resistance was uncommon for imipenem (0.3 % at > 4 mg/l), amoxicillin/clavulanate (1 % at > 8 mg/l), cefoxitin (3 % at > 32 mg/l), mezlocillin (6 % at > 64 mg/l) and clindamycin (9 % at > 4 mg/l). Resistance was the rule for ampicillin (93 % at > 4 mg/l), ciprofloxacin (56 % at > 4 mg/l) and tetracycline (64 % at > 4 mg/l).Bacteroides fragilis, the commonest species, was generally the most sensitive: resistance of this organism was uncommon for cefotetan (4 % at > 32 mg/l) and ceftazidime (12 % at > 32 mg/l) to which the other species were more often resistant. There were small but significant differences between laboratories and countries for many of the antibiotics. Regionally the most striking differences were for clindamycin where resistance inBacteroides fragilis was most common in the South and for tetracycline where resistance inBacteroides fragilis, Bacteroides thetaiotaomicron andBacteroides uniformis was least common in the North.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Phillips I, Eykyn S, Taylor E: Rapid detection of anaerobic bacteria in body fluids. In: Tilton RC (ed): Rapid methods and automation in microbiology. American Society for Microbiology, Washington, DC, 1982, p. 41–44.

    Google Scholar 

  2. Breuil J, Burnat C, Patey O, Dublanchet A: Survey ofBacteroides fragilis susceptibility patterns in France. Journal of Antimicrobial Chemotherapy 1989, 24: 69–75.

    Google Scholar 

  3. Borobio MV, Pascual A, Perea EJ: Increasing resistance ofBacteroides fragilis group strains to metronidazole in Spain between 1977 and 1982. European Journal of Clinical Microbiology 1984, 3: 153–155.

    Google Scholar 

  4. Reig M, Campello MG, Baquero F: Epidemiology of clindamycin resistance in theBacteroides fragilis group. Journal of Antimicrobial Chemotherapy 1984, 14: 595–603.

    Google Scholar 

  5. Garcia-Rodriguez JA, Garcia-Sanchez JE: Evolution of theBacteroides fragilis group antimicrobial susceptibility in Spain. Chemioterapia 1985, 4, Supplement 2: 806–808.

    Google Scholar 

  6. Fox AR, Phillips I: The antibiotic sensitivity of theBacteroides fragilis group in the United Kingdom. Journal of Antimicrobial Chemotherapy 1987, 20: 477–488.

    Google Scholar 

  7. Cuchural GJ, Tally FP, Jacobus NV, Aldridge K, Cleary T, Finegold SM, Iannini P, O'Keefe JP, Pierson C, Crook D, Russo T, Hecht D: Susceptibility of theBacteroides fragilis group in the United States: analysis by site of isolation. Antimicrobial Agents and Chemotherapy 1988, 32: 717–722.

    Google Scholar 

  8. Dubreuil L, Derriennic M, Sedallian A, Romond C, Courtieu AL: Evolution in antibiotic susceptibility ofBacteroides fragilis group strains in France on periodic surveys. Infection 1989, 17: 197–200.

    Google Scholar 

  9. Shannon K, Phillips I: A computer program for the storage and analysis of minimum inhibitory concentrations of antimicrobial agents. Binary 1990, 2: 89–95.

    Google Scholar 

  10. National Committee for Clinical Laboratory Standards: Methods for antimicrobial susceptibility testing of anaerobic bacteria — second edition. Approved Standard M11-A2. NCCLS, Villanova, PA, 1990.

    Google Scholar 

  11. Aldridge KE, Wexler HM, Sanders CV, Finegold SM: Comparison of in vitro antibiograms ofBacteroides fragilis group isolates: differences in resistance rates in two institutions because of differences in susceptibility testing methodology. Antimicrobial Agents and Chemotherapy 1990, 34: 179–181.

    Google Scholar 

  12. Jones RN, Barry AL, Cotton JL, Sutter VL, Swenson JM: Collaborative evaluation of the Micro-Media Systems anaerobe susceptibility panel: comparisons with reference methods and test reproducibility. Journal of Clinical Microbiology 1982, 16: 245–249.

    Google Scholar 

  13. Appelbaum PC, Spangler SK, Jacobs MR: Susceptibilities of 394Bacteroides fragilis, non-B. fragilis groupBacteroides species, andFusobacterium species to newer antimicrobial agents. Antimicrobial Agents and Chemotherapy 1991, 35: 1214–1218.

    Google Scholar 

  14. Betriu C, Campos E, Cabronero C, Rodriguez-Avial C, Picazo JJ: Susceptibilities of species of theBacteroides fragilis group to 10 antimicrobial agents. Antimicrobial Agents and Chemotherapy 1990, 34: 671–673.

    Google Scholar 

  15. Cornick NA, Cuchural GJ, Snydman DR, Jacobus NV, Iannini P, Hill G, Cleary T, O'Keefe JP, Pierson C, Finegold SM: The antimicrobial susceptibility patterns of theBacteroides fragilis group in the United States, 1987. Journal of Antimicrobial Chemotherapy 1990, 25: 1011–1019.

    Google Scholar 

  16. Cuchural GJ, Tally FP, Jacobus NV, Cleary T, Finegold SM, Hill G, Iannini P, O'Keefe JP, Pierson C: Comparative activities of newer β-lactam agents against members of theBacteroides fragilis group. Antimicrobial Agents and Chemotherapy 1990, 34: 479–480.

    Google Scholar 

  17. Bourgault AM, Harding GK, Smith JA, Horsman GB, Marrie TJ, Lamothe F: Survey of anaerobic susceptibility patterns in Canada. Antimicrobial Agents and Chemotherapy 1986, 30: 798–801.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Consortia

Additional information

Prof. J.F. Acar, Paris, France; Dr. F. Baquero, Madrid, Spain; Dr. A. Bremmelgaard, Frederiksberg, Denmark; Prof. J.A. Garcia-Rodriguez, Salamanca, Spain; Prof. U. Höffler, Düsseldorf, Germany; Prof. T. Hofstad, Bergen, Norway; Dr. H. Jousimies-Somer, Helsinki, Finland; Prof. N.J. Legakis, Athens, Greece; Prof. D.M. MacLaren, Amsterdam, Netherlands; Dr. P. Maes, Oostende, Belgium; Dr. G.J. Meijer-Severs, Groningen, Netherlands; Dr. H. Mittermayer, Linz, Austria; Prof. C.-E. Nord, Stockholm, Sweden; Prof. G. Panichi, Rome, Italy; Prof. I. Phillips, London, UK; Prof. G. Privitera, Milan, Italy; Dr. A. Sedallian, Annecy, France; Prof. S. Tabaqchali, London, UK; Prof. A. Torres Pereira, Lisbon, Portugal; Prof. U. Ullmann, Kiel, Germany; Prof. J. Wüst, Zurich, Switzerland; Prof. E. Yourassowsky, Brussels, Belgium.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Phillips, I., King, A., Nord, C.E. et al. Antibiotic sensitivity of theBacteroides fragilis group in Europe. Eur. J. Clin. Microbiol. Infect. Dis. 11, 292–304 (1992). https://doi.org/10.1007/BF01962068

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01962068

Keywords

Navigation